Direct determination of propranolol in urine by spectrofluorimetry with the aid of second order advantage.
This work presented an application of the second-order advantage provided by parallel factor analysis (PARAFAC) aiming at direct determination of propranolol, a beta-blocker also used as doping agent, in human urine by spectrofluorimetry. The adopted strategy combined the use of PARAFAC, for extraction of the pure analyte signal, with the standard addition method, for a determination in the presence of an individual matrix effect caused by the quenching action of the proteins present in the urine. The urine samples were previously 100 times diluted. For each sample, four standard additions were performed, in triplicates. A specific PARAFAC model was built for each triplicate of each sample, from three-way arrays formed by 231 emission wavelengths, 8 excitation wavelengths and 5 measurements (sample plus 4 additions). The models were built with three factors and always explained more than 99.87% of the total variance. The obtained loadings were related to PRO and two background interferences. The scores related to PRO were used for a linear regression in the standard addition method. The obtained determinations in the PRO concentration range from 5.0 to 20.0 microg ml(-1) provided recoveries between 91.1 and 108.4%.
Silva
Lucas C
LC
Unidade Universitária de Ciências Exatas e Tecnológicas, Universidade Estadual de Goiás, P.O. Box 459, 75000-000 Anápolis, GO, Brazil.
Trevisan
Marcello G
MG
Poppi
Ronei J
RJ
Sena
Marcelo M
MM
D002626:Chemistry, Pharmaceutical / Q000379:methods*; D006801:Humans; D008297:Male; D011433:Propranolol / Q000032:analysis / Q000302:isolation & purification / Q000652:urine*; D013050:Spectrometry, Fluorescence / Q000379:methods
D011433:Propranolol